13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

Clinical trials : 3,340 /  Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

  
1 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04634994
(ClinicalTrials.gov)		August 20219/11/2020Novel Assessment of Synaptic Density in Progressive MSNovel Assessment of Synaptic Density in Progressive MSPrimary Progressive Multiple Sclerosis;Secondary Progressive Multiple Sclerosis;Relapsing Multiple Sclerosis;Multiple SclerosisDrug: [F-18]SDM-8Brigham and Women's HospitalMassachusetts General HospitalRecruiting18 Years60 YearsAll30Early Phase 1United States